Statistics about Health, Pharma & Medtech in United States
Statistics
- Most prescribed hearing aid brands or manufacturers among U.S. audiologists 2018
- Annual change in U.S. hearing aid sales by sector 2007-2018
- Adoption rate of hearing aids by HI people in select developed countries 2014-2015
- Safety and independence due to hearing aids in select developed countries 2014-2015
- Relationship improvement due to hearing aids in select developed countries 2014-2015
- Satisfaction with hearing aids in select developed countries 2014-2015
- Sales market share of hearing aid companies U.S. 2015
- FDA support for over the counter hearing aids by industry and consumers US 2015
- FDA support for over the counter hearing aids by surveyed group U.S. 2015
- Annual change in U.S. hearing aid sales 2007-2022
- Use of various hearing aids by market share in U.S. 2021
- Value of medical device imports from the U.S. to Taiwan 2014-2019
- U.S. adults with hearing trouble who had used a hearing aid 2014, by age
- Improved life quality due to hearing aids in select developed countries 2014-2015
- Average hours hearing aids are worn per day in select developed countries 2014-2015
- Number of retail outlets of hearing aid companies U.S. 2015
- Main medical chatbot applications for patients in the U.S. in 2023
- Preferred methods of choice for sharing wearable health data in the U.S. 2023
- Reasons for sharing data from personal devices with doctors in the U.S. 2023
- Doctors' trust in chatbots' abilities in the U.S. in 2023
- Likelihood of choosing a doctor who uses wearable data in the U.S. 2023
- Number of hearing aid specialists in U.S. 2012-2023
- US private hearing aid market by company 2016
- Livestock antimicrobial drugs sales growth in the U.S. by drug class 2012-2021
- U.S. biological product manufacturing gross output 1998-2016
- Opinion on drug spending reduction due to biosimilars for specialty drugs 2017-2020
- New U.S. biosimilar launches of top products 2024-2029
- U.S. public bioscience firms by revenue size class
- YTD stock performance of biopharma companies working on COVID March 2020
- Adalimumab wholesale acquisition cost in the U.S. 2024
- U.S. academic bioscience research and development expenditure by field
- Share of filgrastim sales attributable to Neupogen or biosimilars US 2015-2024
- Share of adalimumab sales Humira vs. biosimilars U.S. 2024
- Humira U.S. price change 2021-2022
- U.S. bioscience-related patents by segment 2019-2023
- Share of insuline glargine sales Lantus vs. biosimilar US 2015-2024
- Comparison WAC of Remicade vs biosimilars in the U.S. as of Q4 2024
- Comparison ASP of Remicade vs biosimilars in the U.S. Q4 2024
- Loss of Neupogen sales to U.S. biosimilars 2015-2017
- Comparison ASP Herceptin vs biosimilars in the U.S. Q4 2024
- Comparison WAC of Herceptin vs biosimilars in the U.S. Q4 2024
- Regeneron Pharmaceuticals top product net sales 2020-2023
- Number of biosimilars approved by FDA 2015-2023
- Antimicrobial drugs for livestock sales distribution by indication U.S. 2009-2023
- Top U.S. states based on academic bioscience R&D expenditure 2022
- Medical cannabis market size in the United States by type 2019 and 2025
- Physician office payment for biosimilars in Medicare Part B 2022
- Amount of top U.S. biotech venture financings 2023
- Alliances U.S. and Europe biotech companies by total potential value 2023
- U.S. top prescribed drugs based on sales 2023
- Reduction in U.S. direct spending on originator biologics as of 2018
- U.S. biotech industry R&D expense
- U.S. biotech industry revenues
- Gross profit margin of select U.S. biotech and drugs companies Q3 2023
- U.S. spending on biosimilars by type 2014
- Top branded biologic drugs in the U.S. that will go generic by 2028
- Number of biotech companies in the U.S. 2012-2016
- Total genetics funding by National Institutes for Health 2013-2025
- biotechnology funding by National Institutes for Health 2013-2025
- Total stem cell research funding by the National Institutes for Health 2013-2025
- Value of top U.S. biotech IPOs 2023
- CBD pharmaceuticals market size in the United States 2019-2026
- Cumulative number of drugs with biosimilars approved US and Europe 2006-2018
- U.S. bioscience venture capital investments 2009-2023
- Number of U.S. bioscience establishments by subsectors 2023
- U.S. bioscience establishments totals 2019-2023
- U.S. bioscience employment totals 2019-2023
- U.S. bioscience employment distribution 2023 by subsector
- U.S. average annual wages per employee by industry 2023
- U.S. states with large employment in drugs and pharmaceuticals 2023
- Safety of childhood vaccination, public opinion in the U.S. 2020, by education level
- U.S. metropolitan areas by employment in research and medical laboratories 2023
- Loss of Lantus sales to U.S. biosimilars 2015-2017
- U.S. bioscience-related patents number 2009-2023
- CBD market size distributed by pharmacies and practitioners in the U.S. 2019-2026
- CAGR of the biosimilars market in Europe and the United States 2018-2025
- U.S. bioscience industry revenue by subsector
- Market capitalization of U.S. biotech companies by region 2021
- COVID-19 vaccination intentions in the U.S. 2021, by gender
- Number of patents granted for the top selling U.S. drugs 2022
- Projection of top 2024 pharma and biotech launches by revenue 2028
- Top drugs advertised to consumers in the U.S. in 2018, by total DTCA spending
- Value of biological product manufacturing shipments 1998-2011
- Annual Medicare spending growth of top U.S. drugs 2017-2021
- Number of patent applications filed for top U.S. drugs 2022
- COVID-19 vaccinations administered in the U.S. as of April 2023, by manufacturer
- COVID-19 vaccination intentions in the U.S. 2021, by age
- BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
- U.S. biotech companies market capitalization 1994-2016
- COVID-19 vaccine and willingness among U.S. adults Dec 2020 - Apr 2022
- Select COVID-19 vaccine pricing and funding as of August 2020
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- United States biotech financing data 2015-2020
- Antimicrobial drugs for livestock total sales U.S. 2009-2023
- Cumulative potential biosimilars market in EU5 countries and the U.S. 2016-2020
- U.S. industrial biotech-related sales in chemicals
- Public U.S. biotech companies R&D spending by region 2021
- U.S. public biotech companies revenue by region 2021
- Number of public biotech companies in the U.S. 2021 by region
- Price increase of top selling drugs U.S. 2016-2021